Results
1 -
10 of
65Drugu2013Drug Interactions Between the Anti-Hepatitis??C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers, Clinical Pharmacokinetics Hepatitis B and Hepatitis C Antiviral Agents, Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions Management of HCV Infection, Handbook of Hepatitis C Features of the Second Wave of the First Generation Protease Inhibitors: Effect and Tolerance, Hepatitis C Virus Treatment Therapie der Hepatitis??C, Der Internist Schritt f??r Schritt zur perfekten Hepatitis-C-Therapie f??r alle Genotypen, Der Internist Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient, European Journal of Clinical Pharmacology Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis, Journal of Gastroenterology Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna, Wiener klinische Wochenschrift Anti-HCV treatment with ombitasvir/paritaprevir/ritonavir???? dasabuvir is associated with increased bile acid levels and pruritus, Wiener klinische Wochenschrift